Report: Cook stent meets safety, effectiveness goals

Zilver PTX, a drug-coated stent from Cook Medical, met safety and effectiveness goals for treating blocked femoral arteries, FDA staff said. Their findings came in a report issued ahead of an Oct. 13 meeting of outside experts who will weigh in on whether to clear the device. The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg. News